FORMULATION AND EVALUATION OF LEVOFLOXACIN-CHITOSAN / Î²- CYCLODEXTRIN NANOPARTICLES BY IONIC GELATION
Background: Levofloxacin is a broad spectrum anti-infective agent, which is rapidly and completely absorbed after oral administration. The half life of Levofloxacin is 6-8 h after conventional dosing. The objective of the present work was to develop Levofloxacin nanoparticles to retain the dosage form in the absorption site more than the half life of the drug, enhance the bioavailability of drugs, reduce dose frequency, toxicity and patient compliance.
Methods: The compositions of different formulations of Levofloxacin nanoparticles by the ionic gelation method using biodegradable polymer chitosan and tripolyphosphate as cross linking agent.
Result and Discussion: The particle size lies of the prepared nanoparticles between 199 and 369 nm and the drug content found between 51.13Â± 0.28 and 71.12 Â± 0.14 %. The particle size of nanoparticles increased with increasing concentration of polymer matrix density and this may be due to the increased viscosity of the inner phase and decreased with increasing concentration of Î²-cyclodextrin. Scanning electron microscopy indicated that the prepared nanoparticles were discrete, uniform and spherical with a smooth surface. The in vitro release showed that the drug release from the prepared nanoparticles was characterized by an initial fast release and followed by a delayed release phase. During and at the end of the accelerated stability study, the tested formulation showed almost same drug content, in vitro drug release and no colour changes were observed from that observed at the opening of the study.
Conclusion: Among all the formulations (GIA, GIB, GIC, GID, GIE and GIF), the formulations G1C, G1E and G1F followed the drug release in a controlled manner. The in vitro release profile showed that this is a potential drug delivery for Levofloxacin and has to confirm in the in vivo settings as a separate investigation in future.
Key words: Controlled drug delivery, In vitro drug release, Nanoparticle, Particle size, Stability studies, Surface morphology
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).